Feedback / Questions
ALTA-3263 - Alterome Therap
https://www.businesswire.com/news/home/20241025855467/en/Alterome-Therapeutics-to-Present-Preclinical-Data-for-its-KRAS-Selective-Inhibitor-ALTA3263-at-the-2024-ENA-Symposium
Oct 25, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next